scispace - formally typeset
Open AccessJournal ArticleDOI

Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.

Reads0
Chats0
TLDR
It is concluded that plasma levels of BNP mainly reflect the degree of ventricular overload and that the secretion patterns of ANP and BNP vary with underlying cardiac disorders of CHF with different degrees of overload in atria and ventricles.
Abstract
BACKGROUNDThe plasma levels of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are increased in relation to the severity of congestive heart failure (CHF). This study was designed to examine whether the secretion patterns of ANP and BNP vary with underlying cardiac disorders of CHF with different degrees of overload in atria and ventricles.METHODS AND RESULTSWe measured plasma levels of ANP and BNP in the aorta in 20 patients with mitral stenosis (MS) in whom atria are mainly overloaded, 30 patients with dilated cardiomyopathy (DCM) in whom both atria and ventricles are overloaded, and 20 control subjects during cardiac catheterization. Pulmonary capillary wedge pressure (PCWP) was significantly higher in the MS and DCM groups (16.7 +/- 4.7 mm Hg and 15.1 +/- 7.7 mm Hg, respectively) than in the control group (7.2 +/- 1.1 mm Hg, p < 0.01), whereas there was no significant difference between the MS and DCM groups. Left ventricular end-diastolic pressure (LVEDP) was significantly higher...

read more

Citations
More filters
Journal ArticleDOI

Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.

TL;DR: Examination of the sources and mechanisms of the secretion of BNP in comparison with those of ANP in control subjects and in patients with heart failure concludes that BNP is secreted mainly from the left ventricle in normal adult humans as well as in Patients with left ventricular dysfunction.
Journal ArticleDOI

The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.

TL;DR: A single measurement of B-type natriuretic peptide, obtained in the first few days after the onset of ischemic symptoms, provides powerful information for use in risk stratification across the spectrum of acute coronary syndromes, and suggests that cardiac neurohormonal activation may be a unifying feature among patients at high risk for death after acute coronary syndrome.
Journal ArticleDOI

B-type natriuretic peptide in cardiovascular disease

TL;DR: Measurement of circulating concentrations of B-type natriuretic peptide and the N-terminal fragment of its prohormones and use of recombinant human BNP (nesiritide) and vasopeptidase inhibitors to treat heart failure are focused on.
Journal ArticleDOI

Attenuation of Compensation of Endogenous Cardiac Natriuretic Peptide System in Chronic Heart Failure Prognostic Role of Plasma Brain Natriuretic Peptide Concentration in Patients With Chronic Symptomatic Left Ventricular Dysfunction

TL;DR: It is indicated that plasma BNP is more useful than ANP for assessing the mortality in patients with chronic CHF and that the plasma levels of BNP provide prognostic information independent of other variables previously associated with a poor prognosis.
Journal ArticleDOI

Utility of B-Natriuretic Peptide in Detecting Diastolic Dysfunction Comparison With Doppler Velocity Recordings

TL;DR: A rapid assay for BNP can reliably detect the presence of diastolic abnormalities on echocardiography, and in patients with normal systolic function, elevated BNP levels and diastsolic filling abnormalities might help to reinforce the diagnosis diastolics dysfunction.
References
More filters
Journal ArticleDOI

A new natriuretic peptide in porcine brain

TL;DR: The brain natriuretic peptide (BNP) as mentioned in this paper was identified in porcine brain of a novel peptide of 26 amino acid residues, eliciting a pharmacological spectrum very similar to that of ANP.
Journal ArticleDOI

Atrial Natriuretic Peptide Elevation in Congestive Heart Failure in the Human

TL;DR: It is established that elevated cardiac filling pressure is associated with increased circulating concentrations of atrial natriuretic peptide and that congestive heart failure is not characterized by a deficiency in atrialNatriureic peptide, but with its elevation.
Journal ArticleDOI

Left retrograde cardioangiography in acquired cardiac disease: Technic, indications and interpretations in 700 cases∗

TL;DR: Application of retrograde left cardioangiography to 700 patients, both adults and children, with acquired valvular diseases is described, and the value of this information in the surgical management of many forms of cardiac disease is emphasized.
Journal ArticleDOI

Atrial Natriuretic Peptide and Atrial Pressure in Patients with Congestive Heart Failure

TL;DR: The release of atrial natriuretic peptide is at least partly regulated by right and left atrial pressures, and the role of peptide release in the pathogenesis of heart failure will require further investigation.
Journal ArticleDOI

Atriopeptin: a cardiac hormone intimately involved in fluid, electrolyte, and blood-pressure homeostasis.

TL;DR: This review focuses on the recent discovery of atriopeptin, a peptide hormone that is intimately involved in the regulation of renal and cardiovascular homeostasis.
Related Papers (5)